John Van Buiten's Insider Trades & SAST Disclosures
John Van Buiten's most recent trade in Hall of Fame Resort & Entertainment Company was a trade of 192 Common Stock done at an average price of $1.3 . Disclosure was reported to the exchange on Jan. 24, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern John Van Buiten.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Hall of Fame Resort & Ente... | John Van Buiten | VP of Accounting/Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.26 per share. | 24 Jan 2025 | 192 | 2,100 | - | 1.3 | 242 | Common Stock |
| Hall of Fame Resort & Ente... | Van Buiten John | VP of Accounting/Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.12 per share. | 20 Dec 2024 | 64 | 2,292 | - | 1.1 | 72 | Common Stock |
| Hall of Fame Resort & Ente... | Van Buiten John | VP of Accounting/Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.70 per share. | 24 Jan 2024 | 192 | 2,356 | - | 3.7 | 710 | Common Stock |
| Hall of Fame Resort & Ente... | Van Buiten John | VP of Accounting/Controller | Sale of securities on an exchange or to another person at price $ 3.31 per share. | 26 Dec 2023 | 75 | 2,548 | - | 3.3 | 248 | Common Stock |
| Enveric Biosciences Inc | John Van Buiten | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2021 | 25,000 | 25,000 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges